본문 바로가기
KERD
논문KCI 등재

Effect of chronic kidney disease on outcomes of total joint arthroplasty: a meta-analysis

Hyun Jung Kim|이승준|왕립|Chang-Wan Kim|Chang-Rack Lee
대한슬관절학회 (Korean Knee Society)|2020.12|Knee Surgery and Related Research|제32권 |pp. 12-12|DOI 10.1186/s43019-020-0029-8

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

MortalityDialysisMorbidityChronic kidney diseaseArthroplastyOutcomes

초록

Background: This meta-analysis was conducted to evaluate the differences in preoperative comorbidities, postoperative mortality, the rate of periprosthetic joint infection (PJI), and revision rate after total joint arthroplasty (TJA) between patients with chronic kidney disease (CKD)(CKD group) and patients with normal kidney function (non-CKD group). Methods: We searched MEDLINE, EMBASE, and the Cochrane Library for studies assessing the effect of CKD on TJA outcome. This meta-analysis included studies that (1) compared the outcomes of TJA between the CKD and non-CKD groups; (2) compared the outcomes of TJA based on CKD stage; and (3) evaluated the risk factors for morbidity or mortality after TJA. We compared the mortality, PJI, and revision rate between CKD and non-CKD groups, and between dialysis-dependent patients (dialysis group) and non-dialysis-dependent patients (non-dialysis group). Results: Eighteen studies were included in this meta-analysis. In most studies that assessed preoperative comorbidities, the number and severity of preoperative comorbidities were reported to be higher in the CKD group than in the non-CKD group. The risk of mortality was found to be higher in the CKD and dialysis groups compared with the respective control groups. In the studies based on administrative data, the unadjusted odds ratio (OR) of PJI was significantly higher in the CKD group than in the non-CKD group; however, no significant difference between the groups was noted in the adjusted OR. After total hip arthroplasty (THA), the risk of PJI was higher in the dialysis group than in the non-dialysis group. No significant difference was noted between the groups in the rate of PJI following total knee arthroplasty. The revision rate did not significantly differ between the CKD and non-CKD groups in the studies that were based on administrative data. However, the unadjusted OR was significantly higher in the dialysis group than in the non-dialysis group. Conclusions: Preoperative comorbidities and mortality risk were higher in the CKD and dialysis groups than in their respective control groups. The risk of revision was greater in the dialysis group than in the non-dialysis group, and the risk of PJI in the dialysis group became even greater after THA. Surgeons should perform careful preoperative risk stratification and optimization for patients with CKD scheduled to undergo TJA.

Abstract

Background: This meta-analysis was conducted to evaluate the differences in preoperative comorbidities, postoperative mortality, the rate of periprosthetic joint infection (PJI), and revision rate after total joint arthroplasty (TJA) between patients with chronic kidney disease (CKD)(CKD group) and patients with normal kidney function (non-CKD group). Methods: We searched MEDLINE, EMBASE, and the Cochrane Library for studies assessing the effect of CKD on TJA outcome. This meta-analysis included studies that (1) compared the outcomes of TJA between the CKD and non-CKD groups; (2) compared the outcomes of TJA based on CKD stage; and (3) evaluated the risk factors for morbidity or mortality after TJA. We compared the mortality, PJI, and revision rate between CKD and non-CKD groups, and between dialysis-dependent patients (dialysis group) and non-dialysis-dependent patients (non-dialysis group). Results: Eighteen studies were included in this meta-analysis. In most studies that assessed preoperative comorbidities, the number and severity of preoperative comorbidities were reported to be higher in the CKD group than in the non-CKD group. The risk of mortality was found to be higher in the CKD and dialysis groups compared with the respective control groups. In the studies based on administrative data, the unadjusted odds ratio (OR) of PJI was significantly higher in the CKD group than in the non-CKD group; however, no significant difference between the groups was noted in the adjusted OR. After total hip arthroplasty (THA), the risk of PJI was higher in the dialysis group than in the non-dialysis group. No significant difference was noted between the groups in the rate of PJI following total knee arthroplasty. The revision rate did not significantly differ between the CKD and non-CKD groups in the studies that were based on administrative data. However, the unadjusted OR was significantly higher in the dialysis group than in the non-dialysis group. Conclusions: Preoperative comorbidities and mortality risk were higher in the CKD and dialysis groups than in their respective control groups. The risk of revision was greater in the dialysis group than in the non-dialysis group, and the risk of PJI in the dialysis group became even greater after THA. Surgeons should perform careful preoperative risk stratification and optimization for patients with CKD scheduled to undergo TJA.

참고문헌 (46)

  1. Corten K, "What works best, a cemented or cementless primary total hip arthroplasty? : Minimum 17-year followup of a randomized controlled trial", Clin Orthop Relat Res, 469(1), pp.209~217 (2011)
  2. Kim YH, "The clinical outcome of computer-navigated compared with conventional knee arthroplasty in the same patients: a prospective, randomized, double-blind, long-term study", J Bone Joint Surg Am, 99(12), pp.989~996 (2017)
  3. Shan L, "Intermediate and longterm quality of life after total knee replacement : a systematic review and meta-analysis", J Bone Joint Surg Am, 97(2), pp.156~168 (2015)
  4. Baumgartner BT, "Inpatient consults and complications during primary total joint arthroplasty in a bundled care model", J Arthroplasty, 33(4), pp.973~975 (2018)
  5. Cancienne JM, "Complication rates after total hip and knee arthroplasty in patients with hepatitis c compared with matched control patients", J Am Acad Orthop Surg, 25(12), pp.e275~e281 (2017)
  6. George J, "Readmission, reoperation, and complications : total hip vs total knee Arthroplasty", J Arthroplasty, 33(3), pp.655~660 (2018)
  7. Baker PN, "The effect of surgical factors on early patient-reported outcome measures(proms)following total knee replacement", J Bone Joint Surg Br, 94(8), pp.1058~1066 (2012)
  8. Hustedt JW, "Calculating the cost and risk of comorbidities in total joint arthroplasty in the United States", J Arthroplast, 32(2), pp.355~361 (2017)
  9. Jiang SL, "Increased rates of periprosthetic joint infection in patients with cirrhosis undergoing total joint arthroplasty", Clin Orthop Relat Res, 472(8), pp.2483~2491 (2014)
  10. Zhu Y, "Risk factors for periprosthetic joint infection after total joint arthroplasty : a systematic review and meta-analysis", J Hosp Infect, 89(2), pp.82~89 (2015)
  11. Abbott KC, "Total hip arthroplasty in chronic dialysis patients in the United States", J Nephrol, 16(1), pp.34~39 (2003)
  12. Coresh J, "Prevalence of chronic kidney disease in the United States", JAMA, 298(17), pp.2038~2047 (2007)
  13. Jha V, "Chronic kidney disease : global dimension and perspectives", Lancet, 382(9888), pp.260~272 (2013)
  14. Warth LC, "Total joint arthroplasty in patients with chronic renal disease: is it worth the risk?", J Arthroplast, 30(9 Suppl), pp.51~54 (2015)
  15. Erkocak OF, "Incidence of infection and inhospital mortality in patients with chronic renal failure after total joint arthroplasty", J Arthroplast, 31(11), pp.2437~2441 (2016)
  16. Fukunishi S, "Results of total hip arthroplasty for dialysis arthropathy in long-term hemodialysis patients", J Orthop Sci, 14(3), pp.285~291 (2009)
  17. Himmelfarb J, "Hemodialysis complications", Am J Kidney Dis, 45(6), pp.1122~1131 (2005)
  18. Tejwani NC, "Renal osteodystrophy", J Am Acad Orthop Surg, 14(5), pp.303~311 (2006)
  19. Maradit Kremers H, "Diabetes mellitus and hyperglycemia and the risk of aseptic loosening in total joint arthroplasty", J Arthroplast, 32(9S), pp.S251~S253 (2017)
  20. Mathew A, "Chronic kidney disease and postoperative mortality : a systematic review and meta-analysis", Kidney Int, 73(9), pp.1069~1081 (2008)
  21. Deegan BF, "Impact of chronic kidney disease stage on lower-extremity arthroplasty", Orthopedics, 37(7), pp.e613~e618 (2014)
  22. Kuo LT, "Chronic kidney disease is associated with a risk of higher mortality following total knee arthroplasty in diabetic patients : a nationwide population-based study", Oncotarget, 8(59), pp.100288~100295 (2017)
  23. Miric A, "The effect of chronic kidney disease on total hip arthroplasty", J Arthroplast, 29(6), pp.1225~1230 (2014)
  24. Miric A, "Can total knee arthroplasty be safely performed in patients with chronic renal disease?", Acta Orthop, 85(1), pp.71~78 (2014)
  25. Patterson JT, "Dialysis dependence predicts complications, intensive care unit care, length of stay, and skilled nursing needs in elective primary total knee and hip arthroplasty", J Arthroplast, 33(7), pp.2263~2267 (2018)
  26. Ponnusamy KE, "Inpatient mortality and morbidity for dialysis-dependent patients undergoing primary total hip or knee arthroplasty", J Bone Joint Surg Am, 97(16), pp.1326~1332 (2015)
  27. Bedard NA, "Does preoperative opioid use increase the risk of early revision total hip arthroplasty?", J Arthroplasty, 33(7), pp.S154~S156 (2018)
  28. Bedard NA, "Preoperative opioid use and its association with early revision of total knee arthroplasty", J Arthroplasty, 33(11), pp.3520~3523 (2018)
  29. Boniello AJ, "Complications and mortality following total hip arthroplasty in the octogenarians : an analysis of a national database", J Arthroplasty, 33(7), pp.S167~S171 (2018)
  30. Cavanaugh PK, "Complications and mortality in chronic renal failure patients undergoing total joint arthroplasty : a comparison between dialysis and renal transplant patients", J Arthroplast, 31(2), pp.465~472 (2016)
  31. Kildow BJ, "Postoperative impact of diabetes, chronic kidney disease, hemodialysis, and renal transplant after total hip Arthroplasty", J Arthroplasty, 32(9S), pp.S135~S140 (2017)
  32. McCleery MA, "Rates of infection and revision in patients with renal disease undergoing total knee replacement in scotland", J Bone Joint Surg Br, 92(11), pp.1535~1539 (2010)
  33. Kuo FC, "Chronic kidney disease is an independent risk factor for transfusion, cardiovascular complication, and thirty-day readmission in minimally invasive total knee arthroplasty", J Arthroplast, 32(5), pp.1630~1634 (2017)
  34. Lizaur-Utrilla A, "Elective total knee arthroplasty in patients with endstage renal disease: Is it a safe procedure?", J Arthroplast, 31(10), pp.2152~2155 (2016)
  35. Marya SKS, "Impact of charlson indices and comorbid conditions on complication risk in bilateral simultaneous total knee arthroplasty", Knee, 23(6), pp.955~959 (2016)
  36. Nikkinen O, "Chronic kidney disease and acute kidney injury in arthroplasty patients over 65 years of age", Acta Anaesthesiol Scand, 63(7), pp.859~870 (2019)
  37. National Kidney F, "K", doqi clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, 2002, pp.39(2 Suppl 1), S1~S266
  38. Bozic KJ, "Risk factors for early revision after primary total hip arthroplasty in Medicare patients", Clin Orthop Relat Res, 472(2), pp.449~454 (2014)
  39. Inneh IA, "Focused risk analysis : regression model based on 5, 314 total hip and knee arthroplasty patients from a single institution", J Arthroplasty, 29(10), pp.2031~2035 (2014)
  40. Singh JA, "Medical and psychological comorbidity predicts poor pain outcomes after total knee arthroplasty", Rheumatology(United Kingdom), 52(5), pp.916~923 (2013)
  41. Quan H, "Coding algorithms for defining comorbidities in ICD-9-cm and ICD-10 administrative data", Med Care, 43(11), pp.1130~1139 (2005)
  42. Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies : development and validation", J Chronic Dis, 40(5), pp.373~383 (1987)
  43. Elixhauser A, "Comorbidity measures for use with administrative data", Med Care, 36(1), pp.8~27 (1998)
  44. Brown EA, "Dialysis arthropathy : complication of long term treatment with haemodialysis", Br Med J(Clin Res Ed), 292(6514), pp.163~166 (1986)
  45. Parvizi J, "Definition of periprosthetic joint infection", J Arthroplast, 29(7), pp.1331~ (2014)
  46. Klatt BA, "Solid organ transplant patients experience high rates of infection and other complications after total knee arthroplasty", J Arthroplast, 28(6), pp.960~963 (2013)

관련 논문AI추천

Total knee arthroplasty in dialysis patients: a national in-patient sample-based study of perioperative complicationsDane K. Wukich, Jack Beale, Michel Toutoungy, Nikit Venishetty, Riley Martinez, Senthil Sambandam, Varatharaj Mounasamy대한슬관절학회 · Knee Surgery and Related Research2023 · 제35권 Clinical Outcomes following Primary Hip Replacement Arthroplasties in Patients with Solid Organ Transplantation: A Systematic Review and Meta-Analysis임익주, Chul-Ho Kim, Jeuk Lee대한고관절학회 · Hip and Pelvis2022 · 제34권 제3호Analysis of the risk factors of acute kidney injury after total hip or knee replacement surgery김양욱, 박봉수, 박시형, 이유진, Il Hwan Kim, Jin Han Park, Jung Hae Ko영남대학교 의과대학 · Journal of Yeungnam Medical Science2021 · 제38권 제2호Perioperative Risk Assessment in Patients Aged 75 Years or Older: Comparison between Bilateral and Unilateral Total Knee Arthroplasty김태경, 라호종, 심상준, 이현일, 최영준, 황도연대한슬관절학회 · Knee Surgery and Related Research2014 · 제26권 제4호Hemiarthroplasty in the Hip Fracture Patient with Renal Impairment: To Cement or Not to CementArjunan Edward Kumanan Graetz, Ernest Beng Kee Kwek, Sean Wei Loong Ho, Tong Leng Tan대한고관절학회 · Hip and Pelvis2019 · 제31권 제4호The effect of Parkinson’s disease on total knee arthroplasty: a systematic review and meta-analysisJung Ro Yoon, Seung-Hoon Lee, Tae Hyuck Yoon대한슬관절학회 · Knee Surgery and Related Research2023 · 제35권

이 간행물의 다른 논문 (63건)

Comparison of the postoperative analgesic effect for infiltration between the popliteal artery and the capsule of the posterior knee and that of periarticular multimodal drug injection in total knee arthroplasty: retrospective study in the immediate postoperative period손원용, Ok-Gul Kim, In Seung Lee, Seung-Suk Seo, Dae-Won Jungpp. 1-1Correlation between meniscal extrusion and symptom duration, alignment, and arthritic changes in medial meniscus posterior root tear: research article김동휘, Hyun Hak Kim, 이광철, Dong Hyuk Chapp. 2-2Outcomes and component-positioning in total knee arthroplasty may be comparable between supervised trained surgeons and their supervisorYoshinari Miyamoto, Yozo Katsuragawa, Kazumi Gotopp. 3-3Calcium phosphate injection of symptomatic bone marrow lesions of the knee: what is the current clinical evidence?J. T. K. Melton, D. S. Angadi, D. Edwardspp. 4-4The effect of interleukin-8 in the early stage after anterior cruciate ligament reconstruction with remnant preservationBeom Koo Lee, Ji-Uk Choi, Kyung-Ok Kim, Jae Ang Sim, 박홍기pp. 5-5
원문 보기